We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Dilation Device Treats Persistent Eustachian Tube Dysfunction

By HospiMedica International staff writers
Posted on 26 Sep 2016
Print article
Image: Eustachian tube balloon dilation with the Aera system (Photo courtesy of Dr. Jeeve Kanagalingam).
Image: Eustachian tube balloon dilation with the Aera system (Photo courtesy of Dr. Jeeve Kanagalingam).
A novel dilation system uses a small balloon to treat persistent Eustachian tube dysfunction (ETD), a condition in which pain and other sensations affect the ear.

The Aera Eustachian tube system consists of a balloon catheter that is inserted through the patient’s nose into the Eustachian tube. After insertion, the balloon is inflated for two minutes to open up a pathway for mucus and air to flow through, in order to restore proper function and reduce pressure, pain, or clogged or muffled sensations in the ear. After the Eustachian tube is dilated, the balloon is deflated and removed. The most common adverse events are small tears of the lining of the Eustachian tube, minor bleeding, and worsening of ETD.

In a study involving 299 patients with chronic ETD, 52% of the patients treated with the Aera system had a subsequent normal functioning range as measured by a tympanogram, a method used to measure mobility of the ear drum and pressure inside the ear. The positive results were fourfold higher than in patients treated with conventional medical management using nasal sprays. The Aera system is a product of Acclarent (Menlo Park, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

“The Aera Eustachian tube balloon dilation system is a new treatment option for patients with ETD symptoms,” said Malvina Eydelman, MD, director of the ophthalmic & ENT device division at the FDA Center for Devices & Radiological Health (CDRH). “The Eustachian tube supports hearing by maintaining pressure inside the ear. Restoring function to this important part of the middle ear may provide relief from the pain, discomfort and sensation of ear fullness or blockage associated with ETD.”

“The Acclarent Aera offers a minimally-invasive and promising option for patients suffering from Eustachian tube dysfunction," said Juha Silvola, MD, PhD, a consultant in Otology-Otoneurology at Oslo University Hospital (Norway). “In my initial experiences with the Aera, the device enabled me to safely and successfully dilate my patients' Eustachian tubes.”

The Eustachian tube is a narrow passage leading from the pharynx to the cavity of the middle ear, permitting the equalization of pressure on each side of the eardrum. It is normally filled with air and helps maintain equal pressure inside the ear with the surrounding environment by periodically opening and closing, like a valve. If this function is impaired, as is the case with ETD, it results in discomfort, impaired hearing, persistent ear infections, ringing in the ears (tinnitus) or other symptoms.

Related Links:
Acclarent
Oslo University Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Infant Blood Draw Station
Infant Blood Draw Station

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.